Assignee
HEXAL AG
DE40 patents
Top patents by PatentIndex Score
US6022852AFeb 8, 2000
Pharmaceutical composition containing cyclosporin A
HEXAL AG92 citations98
US6303141B1Oct 16, 2001
Transdermally administrable medicament with ACE inhibitors
HEXAL AG53 citations95
US6284269B1Sep 4, 2001
Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
HEXAL AG246 citations94
US6248758B1Jun 19, 2001
Pharmaceutical antacid
HEXAL AG108 citations94
US6696413B2Feb 24, 2004
Pharmaceutical preparation with cyclosporin A
HEXAL AG26 citations92
US5904930AMay 18, 1999
Transdermal system in the form of a patch comprising a tamoxifen derivative
HEXAL AG37 citations92
US6440513B1Aug 27, 2002
Flat transdermal medicated self-adhesive patch
HEXAL AG26 citations91
US5856359AJan 5, 1999
Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same
HEXAL AG47 citations91
US5738869AApr 14, 1998
Transdermal drug preparation
HEXAL AG54 citations91
US6267990B1Jul 31, 2001
Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
HEXAL AG35 citations89
US7220473B2May 22, 2007
Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system
HEXAL AG23 citations88
US6579536B1Jun 17, 2003
Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
HEXAL AG56 citations88
US6623752B1Sep 23, 2003
Patch for transdermal application for pergolid
HEXAL AG24 citations87
US6537970B1Mar 25, 2003
Pharmaceutical composition
HEXAL AG31 citations84
US7344733B2Mar 18, 2008
Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole
HEXAL AG39 citations83
US5874107AFeb 23, 1999
Sustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agent
HEXAL AG12 citations74
USD600353SSep 15, 2009
Covering material
HEXAL AG7 citations73
US6204255B1Mar 20, 2001
Solid, non-deliquescent formulations of sodium valproate
HEXAL AG7 citations73
US6071964AJun 6, 2000
Diclofenac/gamma-cyclodextrin inclusion compounds
HEXAL AG9 citations72
US5972376AOct 26, 1999
Transdermal system of tacrine/selegilin-plaster
HEXAL AG15 citations72
US5989585ANov 23, 1999
Transdermal therapeutic system (TTS) containing vitamin E for the treatment of drug dependency
HEXAL AG12 citations70
USD636882SApr 26, 2011
Covering material
HEXAL AG2 citations62
USD634850SMar 22, 2011
Covering material
HEXAL AG3 citations62
US6165498ADec 26, 2000
Transdermal preparation containing a loratidine metabolite with antihistaminic activity
HEXAL AG3 citations61
US7690494B2Apr 6, 2010
Conveyor device having a filling device for vertical flow of material, without demixing, of powdered media
HEXAL AG7 citations58
US11072605B2Jul 27, 2021
Crystalline brexpiprazole
HEXAL AG0 citations53
US5910320AJun 8, 1999
Tablet or capsule having a content of stable ranitidine hydrochloride form 1
HEXAL AG0 citations52
US11123300B2Sep 21, 2021
Immediate release tablet of a benzothiophene compound
HEXAL AG1 citations51
US6395297B1May 28, 2002
Transdermal preparation contacting a loratidine metabolite with antihistaminic activity
HEXAL AG1 citations51
US11021530B2Jun 1, 2021
Antibody preparation
HEXAL AG0 citations47
US9895497B2Feb 20, 2018
Method for reducing leachables and extractables in syringes
HEXAL AG0 citations47
US10668073B2Jun 2, 2020
Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof
HEXAL AG0 citations45
US10335443B2Jul 2, 2019
Orodispersible film
HEXAL AG0 citations45
US6967033B1Nov 22, 2005
Pharmaceutically active plant preparation for the treatment of migraine
HEXAL AG3 citations45
US10485799B2Nov 26, 2019
Pharmaceutical composition of vortioxetine hydrobromide comprising vortioxetine hydrobromide in a polyethylene oxide matrix
HEXAL AG0 citations40
US9789112B2Oct 17, 2017
Oral pharmaceutical film formulation for bitter tasting drugs
HEXAL AG1 citations35
US10501450B2Dec 10, 2019
Anhydrate-free polymorphically pure micronized crystalline brexpiprazole di-hydrate for use in intramuscular injectable sustained release formulations
HEXAL AG0 citations32
US10732162B2Aug 4, 2020
Method and device for determining the disintegration time of film-shaped pharmaceutical dosage forms
HEXAL AG0 citations26
US9717707B2Aug 1, 2017
Pharmaceutical statin composition
HEXAL AG0 citations24
US10548848B2Feb 4, 2020
Alogliptin formulation
HEXAL AG0 citations22